서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 5 of 5

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2018-01	Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma Javle, Milind; Lowery, Maeve; Shroff, Rachna T.; Weiss, Karl Heinz; Springfeld, Christoph; Borad, Mitesh J.; Ramanathan, Ramesh K.; Goyal, Lipika; Sadeghi, Saeed; Macarulla, Teresa; El-Khoueiry, Anthony; Kelley, Robin Kate; Borbath, Ivan; Choo, Su Pin; Oh, Do-Youn; Philip, Philip A.; Chen, Li-Tzong; Reungwetwattana, Thanyanan; Van Cutsem, Eric; Yeh, Kun-Huei; Ciombor, Kristen; Finn, Richard S.; Patel, Anuradha; Sen, Suman; Porter, Dale; Isaacs, Randi; Zhu, Andrew X.; Abou-Alfa, Ghassan K.; Bekaii-Saab, Tanios Journal of Clinical Oncology, Vol.36 No.3, pp.276-282	DOI
2020-05	Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study Abou-Alfa, Ghassan K.; Sahai, Vaibhav; Hollebecque, Antoine; Vaccaro, Gina; Melisi, Davide; Al-Rajabi, Raed; Paulson, Andrew S.; Borad, Mitesh J.; Gallinson, David; Murphy, Adrian G.; Oh, Do-Youn; Dotan, Efrat; Catenacci, Daniel, V; Van Cutsem, Eric; Ji, Tao; Lihou, Christine F.; Zhen, Huiling; Feliz, Luis; Vogel, Arndt The Lancet Oncology, Vol.21 No.5, pp.671-684	DOI
2020-06	Ivosidenib in IDH1-mutant, chemotherapy-refractory Croatia& cholangiocarcinoma (ClarlDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study Abou-Alfa, Ghassan K.; Macarulla, Teresa; Javle, Milind M.; Kelley, Robin K.; Lubner, Sam J.; Adeva, Jorge; Cleary, James M.; Catenacci, Daniel V.; Borad, Mitesh J.; Bridgewater, John; Harris, William P.; Murphy, Adrian G.; Oh, Do-Youn; Whisenant, Jonathan; Lowery, Maeve A.; Goyal, Lipika; Shroff, Rachna T.; El-Khoueiry, Anthony B.; Fan, Bin; Wu, Bin; Chamberlain, Christina X.; Jiang, Liewen; Gliser, Camelia; Pandya, Shuchi S.; Valle, Juan W.; Zhu, Andrew X. The Lancet Oncology, Vol.21 No.6, pp.796-807	DOI
2020-10	Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF 301 trial Makawita, Shalini; Abou-Alfa, Ghassan K.; Roychowdhury, Sameek; Sadeghi, Saeed; Borbath, Ivan; Goyal, Lipika; Cohn, Allen; Lamarca, Angela; Oh, Do-Youn; Macarulla, Teresa; Shroff, Rachna T.; Howland, Michael; Li, Ai; Cho, Terry; Pande, Amit; Javle, Milind Future Oncology, Vol.16 No.30, pp.2375-2384	DOI
2021-11	Final Overall Survival Efficacy Results of Ivosidenib for Patients with Advanced Cholangiocarcinoma with IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial Zhu, Andrew X.; Macarulla, Teresa; Javle, Milind M.; Kelley, R. Kate; Lubner, Sam J.; Adeva, Jorge; Cleary, James M.; Catenacci, Daniel V. T.; Borad, Mitesh J.; Bridgewater, John A.; Harris, William P.; Murphy, Adrian G.; Oh, Do-Youn; Whisenant, Jonathan R.; Lowery, Maeve A.; Goyal, Lipika; Shroff, Rachna T.; El-Khoueiry, Anthony B.; Chamberlain, Christina X.; Aguado-Fraile, Elia; Choe, Sung; Wu, Bin; Liu, Hua; Gliser, Camelia; Pandya, Shuchi S.; Valle, Juan W.; Abou-Alfa, Ghassan K. JAMA oncology, Vol.7 No.11, pp.1669-1677	DOI

1